Daniela Caramazza

Daniela Caramazza

Auto-generated profile, based on publicly available information

Daniela Caramazza

Gynecological Surgery and Urogynecology Unit, Dipartimento Centro di Eccellenza Donna e Bambino Nascente Ospedale Isola Tiberina Rome Gemelli Isola Italy

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2023 in Frontiers in Surgery
Verified
Journal Article
Open access
GPGiovanni Panico
Giovanni Panico
LVLorenzo Vacca
Lorenzo Vacca
GCGiuseppe Campagna
Giuseppe Campagna
DCDaniela Caramazza
Daniela Caramazza
SMSara Mastrovito
Sara Mastrovito
GSGiovanni Scambia
Giovanni Scambia
Introduction: We present the preliminary report of the first 60 cases of robotic sacrocolpopexy (RSCP) performed with a minimally invasive approach by using the new HUGO RAS system (Medtronic) with the aim of assessing its feasibility, safety and efficacy.Methods: Results in terms of operative time, intraoperative blood loss, post-operative pain, length of hospitalisation, intra and post-operative complications were comparable to previously described laparoscopic and robotic techniques.Results: Urogynecological assessment at three months follow up showed surgical anatomic success in 96.7% of patients (<2 POP-Q stage), while subjective cure rate was 98.3%.Conclusions: This is the first series analyzing RSCP outcomes for POP using the new Hugo RAS system. Our results suggest effectiveness both in objective and subjective outcomes, with minimal intra and post-operative complications. Larger series as well as longer follow-up are needed to better define advantages and possible disadvantages of this novel system. Our work may represent the basis of future studies to confirm its safety, efficacy and feasibility, and may provide technical notes for other centres that wish to perform RSCP through this innovative system.

27 July 2022 in Urologia Internationalis
Verified
Journal Article
Closed access
PDF file
FNFranca Natale
Franca Natale
GCGiuseppe Campagna
Giuseppe Campagna
MMMonia Marturano
Monia Marturano
DCDaniela Caramazza
Daniela Caramazza
GPGiovanni Panico
Giovanni Panico
AEAlfredo Ercoli
Alfredo Ercoli
Introduction: Bladder pain syndrome/interstitial cystitis (BPS/IC) is either Hunner lesion interstitial cystitis (HL IC) or non-Hunner lesion interstitial cystitis (N-HL IC), differing in the presence of HLs on cystoscopy. Cystoscopy is essential in diagnosing HL but are bladder biopsies useful in N-HL IC patients? Our objective was to assess bladder biopsy in patients with N-HL IC, evaluating whether the count of mast cells (MCs) and percentage of activated MCs could measure severity. Materials and Methods: This is a single-centre retrospective study. Inclusion criteria: diagnosis of BPS/IC by ESSIC definition; absence of HLs. Each patient had three bladder biopsies. Statistical analysis: χ2/Fischer’s exact test; Wilcoxon signed-ranks test/Mann-Whitney U test. Statistical significance: p < 0.05. Results: We separated 48 women into Group 1 with 50%. We compared the results of the O’Leary-Sant questionnaire between the two groups and did not find any correlation between the severity of the pathology and either the MC count in the detrusor or the percentage of activated MCs in the lamina propria or detrusor. Discussion/Conclusion: These findings cast doubt on the usefulness of bladder biopsy for the evaluation of severity in N-HL IC.

8 October 2018 in International Urogynecology Journal
Verified
Journal Article
Closed access
PDF file
GCGiuseppe Campagna
Giuseppe Campagna
GPGiovanni Panico
Giovanni Panico
DCDaniela Caramazza
Daniela Caramazza
MMMonia Marturano
Monia Marturano
AEAlfredo Ercoli
Alfredo Ercoli
MCMauro Cervigni
Mauro Cervigni

18 August 2022 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
DCDaniela Caramazza
Daniela Caramazza
GCGiuseppe Campagna
Giuseppe Campagna
FMFrancesca Moro
Francesca Moro
LVLorenzo Vacca
Lorenzo Vacca
MMMonia Marturano
Monia Marturano
ATAntonia Carla Testa
Antonia Carla Testa

16 April 2026 in Acta Obstetricia et Gynecologica Scandinavica
Verified
Journal Article
Open access
PDF file
Martina ArcieriMartina Arcieri
Martina Arcieri
Stefano RestainoStefano Restaino
Stefano Restaino
VTVeronica Tius
Veronica Tius
ALAndrea Lombisani
Andrea Lombisani
DADavide Arrigo
Davide Arrigo
AEAlfredo Ercoli
Alfredo Ercoli
Introduction: Several surgical approaches are available for the repair of complex vesico‐vaginal fistulas; however, robust clinical evidence and standardization of techniques are lacking. Complex vesico‐vaginal fistula is defined as either a recurrent fistula following primary surgical repair or a fistula related to prior pelvic surgery and/or radiotherapy. The aim of this study was to describe a step‐by‐step combined vaginal and laparoscopic technique and to assess its feasibility, safety, and efficacy. Material and Methods: A retrospective study was performed between 2016 and 2023, involving patients diagnosed with complex vesico‐vaginal fistulas. Clinical, perioperative, and postoperative data were collected. The surgical technique was standardized, described, and executed by an experienced surgeon in each case. Postoperative urogynecological follow‐up was scheduled at one month, 3 months, 6 months, and one year. Results: A total of 20 patients were included in the study. Fifteen patients developed vesico‐vaginal fistulas after total hysterectomy, four after radical hysterectomy combined with radiotherapy, and one following a cesarean section. Four patients had a prior diagnosis of gynecological cancer, four had received pelvic radiotherapy, and two had undergone previous chemotherapy. Twenty‐five percent of the patients exhibited VVF in the trigone area. The median operative time was 317 min (ranging from 250 to 508 min). One minor postoperative complication occurred, and there was no conversion to laparotomy. All repairs were watertight. The median length of hospital stay was 4 days (ranging from 2 to 6 days). No recurrences were observed during the follow‐up period, lasting 42 months on average. Conclusions: This study demonstrated the feasibility and safety of a new surgical approach for repairing complex urogenital fistulas.

24 September 2026 in Neurourology and Urodynamics
Verified
Journal Article
Open access
PDF file
LVLorenzo Vacca
Lorenzo Vacca
DCDaniela Caramazza
Daniela Caramazza
MPMichele Pierro
Michele Pierro
AFAniello Foresta
Aniello Foresta
ALAndrea Lombisani
Andrea Lombisani
GCGiuseppe Campagna
Giuseppe Campagna
Background: Pelvic organ prolapse (POP) frequently coexists with overactive bladder (OAB) symptoms, yet the impact of surgical correction on OAB outcomes remains incompletely characterized across different surgical approaches. Objectives: To quantify OAB symptom resolution rates following POP surgery, compare outcomes across surgical techniques, evaluate de novo OAB incidence, and identify predictive factors for postoperative OAB persistence or development. Search Strategy: Comprehensive search of MEDLINE, Embase, Web of Science, Scopus, Cochrane CENTRAL, ClinicalTrials.gov , and LILACS through December 31, 2024, limited to English language articles. Selection Criteria: Comparative studies (randomized controlled trials and observational studies) including adult women with symptomatic POP (POP‐Q stage ≥II) undergoing surgical correction, reporting validated OAB outcomes with minimum 3‐month follow‐up. Data Collection and Analysis: Three independent reviewers extracted data using predefined criteria. Random‐effects meta‐analyses with Freeman‐Tukey double arcsine transformation were performed. Quality assessment employed Cochrane Risk of Bias 2.0, Newcastle‐Ottawa Scale, and GRADE methodology. Main Results: Twenty‐four studies encompassing 7739 women (7095 analyzed) were included. Overall OAB resolution rate was 58.0% (95% CI: 55.9%–60.1%; I 2 = 83.9%). No significant differences emerged between vaginal, laparoscopic/robotic, or abdominal approaches ( p = 0.62), or between mesh‐augmented versus native tissue repairs ( p = 0.48). Compartment‐specific analysis revealed anterior/apical repairs achieved significantly higher resolution (75.8%, 95% CI: 73.2%–78.3%) compared to isolated posterior repairs (28.3%, 95% CI: 20.1%–37.9%; p < 0.001). De novo OAB incidence ranged 0%–14.3%, though reporting was limited to 6 studies. Conclusions: POP surgery resolves preexisting OAB in approximately three‐fifths of patients, with anatomical compartment representing the strongest predictor. Anterior/apical prolapse correction offers superior OAB outcomes compared to posterior repair, independent of surgical approach or mesh utilization.